Fatigue-Fighting supplement tested in liver cancer trial

NCT ID NCT07317414

Recruiting now Symptom relief Sponsor: Peking Union Medical College Hospital Source: ClinicalTrials.gov ↗

First seen Jan 06, 2026 · Last updated Apr 28, 2026 · Updated 16 times

Summary

This study tests whether a dietary supplement called β-alanine can reduce fatigue in people with advanced liver cancer who are receiving standard immunotherapy. About 158 participants will take either β-alanine or a placebo alongside their regular treatment. The main goal is to see if the supplement improves energy levels and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Peking Union Medical College Hospital
RECRUITING

Beijing, Beijing Municipality, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
The Affiliated Hospital of Xuzhou Medical University
RECRUITING

Xuzhou, Jiangsu, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
The First Affiliated Hospital with Nanjing Medical University
RECRUITING

Nanjing, Jiangsu, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEPATOCELLULAR CARCINOMA